Stroke Clinical Trial
— PAPASéPAOfficial title:
Post-stroke Pathway: Analysis and Link With One Year Sequelae in a French Cohort of Stroke Patients
Verified date | March 2022 |
Source | University Hospital, Bordeaux |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The link between post-stroke pathways and patient sequelae have not yet been clearly defined. The main purpose is to identify the post-stroke life pathways components associated with sequalae at 3 months and 1 year after the acute stroke episode.
Status | Active, not recruiting |
Enrollment | 1138 |
Est. completion date | November 18, 2022 |
Est. primary completion date | November 18, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient being over 18 years of age living in metropolitan France; - Patient with recent stroke (not before 2019) whose diagnosis confirmed by a neuro-vascular physician; - Patient managed for stroke in one of the 13 participating hospitals of the Aquitaine region; - Patient giving consent to participate to PAPASéPA; - Patient to be alive at the end of the acute management hospital stay Exclusion Criteria: - Patient refuse to participate to PAPASéPA - Patient died during the initial stay |
Country | Name | City | State |
---|---|---|---|
France | CH Agen | Agen | |
France | CH Blaye | Blaye | |
France | CHU Bordeaux | Bordeaux | |
France | CH Arcachon | La Teste de Buch | |
France | CH Sud Gironde - Langon | Langon | |
France | Clinique Mutualiste Lesparre Médoc | Lesparre-Médoc | |
France | CH Libourne | Libourne | |
France | CHIC Marmande-Tonneins | Marmande | |
France | CH Mont de Marsan - site Layné | Mont de Marsan | |
France | CH Oloron | Oloron-Sainte-Marie | |
France | CH Orthez | Orthez | |
France | CH Pau | Pau | |
France | Pôle de Santé du Villeneuvois | Villeneuve sur Lot |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Bordeaux |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Modified Rankin Scale (mRS) Score | Activity limitations post-stroke measure. Minimum score : 0 "No symptoms at all " Maximum score : 6 "Dead" | 3 months | |
Primary | Modified Rankin Scale (mRS) Score | Activity limitations post-stroke measure Minimum score : 0 "no symptom" Maximum score : 6 "death" | 1 year | |
Secondary | Telephone Interview for Cognitive Status Modified (TICS) Score | Cognitive disorders post-stroke measure Score from 0 to 43 | 3 months | |
Secondary | Telephone Interview for Cognitive Status Modified (TICS) Score | Cognitive disorders post-stroke measure Score from 0 to 43 | 1 year | |
Secondary | Hospital anxiety and depression scale (HADS) Score | Depression and anxiety disorders post-stroke measure Scores ranged from 0 (minimum) to 21 (maximum) for anxiety and 0 (minimum) to 21 (maximum) for depression.
Total score from 0 to 42 |
3 months | |
Secondary | Hospital anxiety and depression scale (HADS) Score | Depression and anxiety disorders post-stroke measure Scores ranged from 0 (minimum) to 21 (maximum) for anxiety and 0 (minimum) to 21 (maximum) for depression.
Total score from 0 to 42 |
1 year | |
Secondary | Fatigue Severity Scale (FSS) Score | The Fatigue Severity Scale (FSS) is designed to differentiate fatigue from clinical depression, since both share some of the same symptoms. Essentially, the FSS consists of answering a short questionaire that requires the subject to rate his or her own level of fatigue. The subject is asked to read each statem ent and circle a number from 1 to 7, depending on how appropriate they felt the statement applied to them over the preceding week. A low value indicates that the statement is not very appropriate whereas a high value indicates agreement. The scoring is done by calculating the average response to the questions (adding up all the answers and dividing by nine).
People with depression alone score about 4.5. People with fatigue average about 6.5. |
3 months | |
Secondary | Fatigue Severity Scale (FSS) Score | The Fatigue Severity Scale (FSS) is designed to differentiate fatigue from clinical depression, since both share some of the same symptoms. Essentially, the FSS consists of answering a short questionaire that requires the subject to rate his or her own level of fatigue. The subject is asked to read each statem ent and circle a number from 1 to 7, depending on how appropriate they felt the statement applied to them over the preceding week. A low value indicates that the statement is not very appropriate whereas a high value indicates agreement. The scoring is done by calculating the average response to the questions (adding up all the answers and dividing by nine).
People with depression alone score about 4.5. People with fatigue average about 6.5. |
1 year | |
Secondary | Barthel Index (BI) Score | Functional outcome post-stroke measure The original 10-item form of the BI consists of 10 common ADL activities including: feeding, bathing, grooming, dressing, bowel control, bladder control, toileting, chair transfer, ambulation and stair climbing. Items are rated in terms of whether individuals can perform activities independently, with some assistance, or are dependent (scored as 10, 5 or 0). Items are weighted according to the level of nursing care required.
Total score from 0 to 100 |
3 months | |
Secondary | Barthel Index (BI) Score | Functional outcome post-stroke measure The original 10-item form of the BI consists of 10 common ADL activities including: feeding, bathing, grooming, dressing, bowel control, bladder control, toileting, chair transfer, ambulation and stair climbing. Items are rated in terms of whether individuals can perform activities independently, with some assistance, or are dependent (scored as 10, 5 or 0). Items are weighted according to the level of nursing care required.
Total score from 0 to 100 |
1 year | |
Secondary | Community Integration Questionnaire (CIQ-R) Score | Participation restrictions post-stroke measure Score from 0 to 35 | 3 months | |
Secondary | Community Integration Questionnaire (CIQ-R) Score | Participation restrictions post-stroke measure Score from 0 to 35 | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Recruiting |
NCT03869138 -
Alternative Therapies for Improving Physical Function in Individuals With Stroke
|
N/A | |
Completed |
NCT04101695 -
Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects
|
N/A | |
Completed |
NCT04034069 -
Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Completed |
NCT00391378 -
Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)
|
N/A | |
Recruiting |
NCT06204744 -
Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial
|
N/A | |
Active, not recruiting |
NCT06043167 -
Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
|
||
Active, not recruiting |
NCT04535479 -
Dry Needling for Spasticity in Stroke
|
N/A | |
Completed |
NCT03985761 -
Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke
|
N/A | |
Recruiting |
NCT00859885 -
International PFO Consortium
|
N/A | |
Recruiting |
NCT06034119 -
Effects of Voluntary Adjustments During Walking in Participants Post-stroke
|
N/A | |
Completed |
NCT03622411 -
Tablet-based Aphasia Therapy in the Chronic Phase
|
N/A | |
Completed |
NCT01662960 -
Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke
|
N/A | |
Recruiting |
NCT05854485 -
Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke
|
N/A | |
Active, not recruiting |
NCT05520528 -
Impact of Group Participation on Adults With Aphasia
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Completed |
NCT05805748 -
Serious Game Therapy in Neglect Patients
|
N/A | |
Recruiting |
NCT05621980 -
Finger Movement Training After Stroke
|
N/A |